TD Asset Management’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.6M | Buy |
|
|||||
|
2025
Q1 | $1.43M | Sell |
|
|||||
|
2024
Q4 | $3.64M | Sell |
|
|||||
|
2024
Q3 | $5.45M | Sell |
|
|||||
|
2024
Q2 | $7.02M | Sell |
|
|||||
|
2024
Q1 | $9.46M | Buy |
|
|||||
|
2023
Q4 | $2.08M | Sell |
|
|||||
|
2023
Q3 | $1.79M | Buy |
|
|||||
|
2023
Q2 | $1.1M | Sell |
|
|||||
|
2023
Q1 | $1.65M | Sell |
|
|||||
|
2022
Q4 | $2.46M | Buy |
|
|||||
|
2022
Q3 | $1.35M | Buy |
|
|||||
|
2022
Q2 | $988K | Sell |
|
|||||
|
2022
Q1 | $2.52M | Buy |
|
|||||
|
2021
Q4 | $2.41M | Hold |
|
|||||
|
2021
Q3 | $3.37M | Buy |
|
|||||
|
2021
Q2 | $1.97M | Buy |
|
|||||
|
2021
Q1 | $471K | Buy |
|
|||||
|
2020
Q4 | $287K | Buy |
|